from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2078/-

LFCtreatmentdescriptionclass of inhibitor

0.090

Amikacinug/mL Amikacintranslation

0.000

Cap5-10ug/mL Capreomycintranslation

0.000

Rox10-50 ug/mL Roxithromycintranslation

1.741

SM2-5 ug/mL Streptomycintranslation

0.000

Tet5-10 ug/mL Tetracyclinetranslation

0.599

Rif0.2-5ug/mL Rifampicintranscription

0.000

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.823

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.745

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.617

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.060

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.593

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.472

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.103

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.200

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.657

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.556

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.119

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.463

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.029

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.276

KCN5-20 ug/mL Potassium cyaniderespiration

-0.193

NaN30.2-2 mM Sodium aziderespiration

1.233

Nigericin50 uM Nigericinrespiration

-0.741

TRC10-150 ug/mL Triclosanrespiration

1.306

TRZ10-25 ug/mL Thioridazinerespiration

0.811

Valinomycin0.5-10 uM Valinomycinrespiration

-2.859

ZnSO42 mM ZnSO4respiration

-0.292

menadione6-10 ug/mL Menadionerespiration

1.084

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

1.092

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

1.497

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.385

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.108

NRP_1Non-replicating persistence stage 1dosRassociated

0.000

Amp0.2mg/mL AmpicillincellWall

0.293

Cephalexin20-100 ug/mL CephalexincellWall

0.431

Cerulenin0.32-5 ug/mL CerulenincellWall

0.348

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.401

EMB10-20 ug/mL EthambutolcellWall

0.000

Eta12-40 ug/mL EthionamidecellWall

-1.215

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.160

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.595

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.925

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.006

BZA0.12 mg/mL BenzamidearomaticAmides

0.428

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.419

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.810

H2O24 mM hydrogen peroxideDNAdamaging

0.000

Levo10 ug/mL LevofloxacinDNAdamaging

0.496

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.238

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.000

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.504

UVUV-irradiationDNAdamaging

-1.168

ARP41-4 ug/mL Antitubercular compound ARP4?

-1.212

Antimycin12.5-50 ug/mL Antimycin A?

-0.184

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-1.126

PA_110-50 ug/mL Antitubercular compound PA-1?

0.329

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.179

PA8240.2-2 ug/mL PA-824?

-0.887

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.102

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.370

Verapamil50 uM Verapamil?

0.789

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.300

methoxatin10-20 ug/mL Methoxatin?